Achieving Justice in Genomic Translation: Re-Thinking the Pathway to Benefit
Oxford University Press, USA, Sep 15, 2011 - Medical - 212 pages
This book explores implicit choices made by researchers, policy makers, and funders regarding who benefits from society's investment in health research. The authors focus specifically on genetic research and examine whether such research tends to reduce or exacerbate existing health disparities. Using case examples to illustrate the issues, the authors trace the path of genetics research from discovery, through development and delivery, to health outcomes. Topics include breast cancer screening and treatment, autism research, pharmacogenetics, prenatal testing, newborn screening, and youth suicide prevention. Each chapter emphasizes the societal context of genetic research and illustrates how science might change if attention were paid to the needs of marginalized populations. Written by experts in genetics, health, and philosophy, this book argues that the scientific enterprise has a responsibility to respond to community needs to assure that research innovations achieve much needed health impacts.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Justice in Translational Science
A Formidable Status Quo
Whose DNA Do We Study and Why Does It Matter?
Changing Pace Priorities and Roles in Discovery Science
5 Early Assessment of Translational Opportunities
How Carrier and Prenatal Screening Altered the Clinical Goals of Genetic Testing
The Role of Guidelines
Other editions - View all
Accessed November advocacy advocates African American AGRE Alaska Native alpha-fetoprotein amniocentesis assessment and priority autism biomedical research BRCA BRCA1 BRCA2 breast cancer Burke carrier screening CF carrier challenges Chapter clinical utility clinicians communities cost cystic fibrosis diabetes disorders drug effects ethnic evaluation evidence example factors families focus funding gene genetic counseling genetic research genetic risk genetic tests genomic discovery groups health disparities Human Genome Human Genome Project identify impact improve health outcomes increased individuals innovations interventions Iversen JAMA medicine mutations newborn screening ofthe ovarian cancer parents participants patients perspective PGx testing pharmacogenetic phase populations potential prenatal prevention public health recommendations regulatory responsive justice result role samples scientific Shestack social stakeholders studies susceptibility Tay-Sachs disease therapy tion translational cycle translational pathway translational research treatment underserved Updated variants warfarin women youth suicide